Geometry.Net - Health_Conditions: Thrombosis

Thrombosis Online
Information on the causes, symptoms, and treatments of DVT, pulmonary embolism, and stroke. Includes free membership area with health tips and tools.
http://www.thrombosisonline.com/
Trauma, Hemostasis And Thrombosis
TRAUMA, HEMOSTASIS AND thrombosis A site focusing on the relationshipbetween trauma, surgery, hemostasis and thrombosis. Click on
http://www.trauma.suite.dk/

Extractions: A site focusing on the relationship between trauma, surgery, hemostasis and thrombosis. Click on... Editors to read about the Editors of this website Click on... Our Own to see a list of relevant publications by the Editors Click on... Others' to see a list of relevant publications by others Click on... Links to see relevant links
Thrombosis Crisis In Hospital Medicine: A Year 2003 DVT-FREE Initiative And Clin
Free continuing medical education symposia from American Health Consultants on acute thrombosis management in emergency medicine.
http://www.ahcpub.com/ahc_root_html/products/conferences/thrombosishm_aventis200

Extractions: Please try our Site Map Course Description Credit Designation Faculty Sponsorship ... Objectives Sponsored by Thomson American Health Consultants, publishers of: and Infectious Disease Alert. This symposium is intended to educate and provide a systematic, state-of-the-art update for hospital-oriented and/or hospital-based primary care physicians, internists, pharmacists, emergency physicians, and medical nurses on issues related to prevention and management of life-threatening arterial and venous thrombosis. The program will begin with a general overview of the thrombosis crisis in clinical medicine, which be followed by an evidence-based update of the latest information on the evaluation and treatment of common cardiovascular, pulmonary, and medical disorders. A question and answer session will follow the last presenter. Top This symposium is designed for all physicians and other healthcare personnel who manage patients in the hospital environment, emergency department, critical care, and acute outpatient settings.
EMedicine - Deep Venous Thrombosis And Thrombophlebitis : Article By Donald Schr
Deep Venous thrombosis and Thrombophlebitis Deep venous thrombosis (DVT) and itssequela, pulmonary embolism, is the leading cause of preventable in-hospital
http://www.emedicine.com/EMERG/topic122.htm

Extractions: document.write(''); (advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Emergency Medicine Cardiovascular Last Updated: January 14, 2002 Rate this Article Email to a Colleague AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials ... Bibliography Author: Donald Schreiber, MD, CM , Assistant Professor of Surgery, Stanford University School of Medicine; Research Director, Division of Emergency Medicine, Stanford University Hospital Donald Schreiber, MD, CM, is a member of the following medical societies: American College of Emergency Physicians Editor(s): Francis Counselman, MD , Program Director, Chair, Professor, Department of Emergency Medicine, Eastern Virginia Medical School; Francisco Talavera, PharmD, PhD , Senior Pharmacy Editor, Pharmacy, eMedicine; Gary Setnik, MD , Chair, Department of Emergency Medicine, Mount Auburn Hospital; Assistant Professor, Division of Emergency Medicine, Harvard Medical School; John Halamka, MD
Economy Class Syndrome - DVT In The Air - Explained By A UK Expert
Information about economy class syndrome and deep vein thrombosis (DVT) including precautions for air travel.
http://www.economy-class.co.uk
EMedicine - Cavernous Sinus Thrombosis : Article By Edward Bessman, MD
Cavernous Sinus thrombosis Cavernous sinus thrombosis (CST) is most commonly alate complication of an infection of the central face or paranasal sinuses.
http://www.emedicine.com/EMERG/topic87.htm

Extractions: (advertisement) Home Specialties CME PDA ... Patient Education Articles Images CME Patient Education Advanced Search Link to this site Back to: eMedicine Specialties Emergency Medicine Neurology Last Updated: September 11, 2001 Rate this Article Email to a Colleague AUTHOR INFORMATION Section 1 of 10 Author Information Introduction Clinical Differentials ... Bibliography Author: Edward Bessman, MD , Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University Edward Bessman, MD, is a member of the following medical societies: American Academy of Emergency Medicine American College of Emergency Physicians , and Society for Academic Emergency Medicine Editor(s): David FM Brown, MD , Instructor, Department of Medicine, Division of Emergency Medicine, Harvard Medical School; Associate Chief, Department of Emergency Medicine, Massachusetts General Hospital; Francisco Talavera, PharmD, PhD , Senior Pharmacy Editor, Pharmacy, eMedicine;
Welcome To WWW.DVT.ORG
Features their Best Practices Preventing Deep Vein thrombosis and Pulmonary Embolism manual in HTML and PDF formats plus information about the treatment of thrombosis.
http://www.umassmed.edu/outcomes/dvt/
Member Sign In
Article describing the goals of the Council for Leadership on thrombosis Awareness and Management.
http://www.medscape.com/viewarticle/426817
Karger Publishers
No. 2, MarchApril 2002 (July 2002). Suppl. 2, Upcoming Issue TentativeTable of Contents ISBN 38055-7498-3 International Congress on thrombosis.
http://www.karger.com/journals/pht/pht_bk.htm
Medical Experts Unite To Raise Awareness Of Risk, Threat Of Blood Clots
Council for Leadership on thrombosis Awareness and Management formed to advance prevention and treatment of thrombosis. Includes disease description and council's education plans.
http://www.eurekalert.org/pub_releases/2002-02/m-meu021302.php

Extractions: MCS Council for Leadership on Thrombosis Awareness and Management formed to advance prevention and treatment of overlooked public health problem TARRYTOWN, NY, February 14, 2002 Calling deep-vein thrombosis (DVT), or blood clots, an underestimated public health problem, the Council for Leadership On Thrombosis (CLOT) Awareness and Management announced its formation today to raise awareness, advance prevention and treatment, and reduce the dangers of DVT, a potentially life-threatening condition that affects approximately 2 million Americans per year. Comprised of medical experts representing various specialties and affiliated with leading U.S. institutions, the Council plans to target both health care professionals and the general public with such major initiatives as a national DVT FREE screening program of 7,500 patients at more than 200 hospitals, and the ClotAlert Resource Center, a multifaceted campaign to educate consumers, physicians and health professionals about the risk factors and symptoms of DVT. Deep-vein thrombosis represents one of the most commonly occurring and serious medical conditions, yet it has never received the same attention as heart attack or stroke, said Samuel Z. Goldhaber, MD, director of Venous Thromboembolism Research Group and Cardiac Centers Anticoagulation Service at Brigham and Womens Hospital in Boston, Mass., associate professor of medicine, Harvard Medical School, and co-chair of the Council for Leadership On Thrombosis Awareness and Management. The public is not nearly as educated about the potential health risk of DVT, nor is the public aware of the symptoms associated with blood clots. Our mission as a Council is to raise awareness of DVT so the public can recognize the symptoms and urgently seek medical help.
Karger Publishers
Journal of The field of haemostasis and thrombosis has witnessed significantdevelopments during the last few decades. The upcoming
http://www.karger.com/journals/pht/pht_jh.htm

Extractions: The field of haemostasis and thrombosis has witnessed significant developments during the last few decades. The upcoming of biochemistry, cell biology and later of molecular biology as new research tools has constantly been reflected in the former Haemostasis. Nevertheless, the journal continued to devote many of its pages to traditional clinical pathophysiology. The new name Pathophysiology of Haemostasis and Thrombosis emphasizes the importance of this constant approach in a world of changing fashions. The journal features original contributions reporting the latest findings on the pathology, physiology and biochemistry of hemorrhagic disease and thrombosis. In addition to in-depth studies of such topics as blood coagulation factors, fibrinolysis, platelets and vascular biology, readers will find extensive data on clinical results with heparin, oral anticoagulants and newer anti-thrombotics. Practical information on the diagnosis and treatment of bleeding disorders and on fibrinolytic treatment are also provided. These experimental and clinical investigations are supported by occasional authoritative reviews to make the journal a full record of current research on thrombosis and haemostasis and its clinical implications.
Guardian Unlimited | Today's Issues | Deep Vein Thrombosis
Deep vein thrombosis A high court ruling today appeared to block DVT victims'hopes of claiming compensation from airlines. What is deep vein thrombosis?
http://www.guardian.co.uk/theissues/article/0,6512,489376,00.html

Extractions: Go to: Guardian Unlimited home UK news World news Archive search Arts Books Business EducationGuardian.co.uk Film Football Jobs MediaGuardian.co.uk Money The Observer Online Politics Shopping SocietyGuardian.co.uk Sport Talk Travel Audio Email services Special reports The Guardian The weblog The informer The northerner The wrap Advertising guide Crossword Dating Headline service Syndication services Events / offers Help / contacts Information Newsroom Style guide Travel offers TV listings Weather Web guides Guardian Weekly Money Observer Home UK Business Online ... Quiz
Guardian Unlimited | Online | Beware 'e-thrombosis': It Could Be Terminal
Beware 'ethrombosis' it could be terminal Staff and agencies Wednesday January29, 2003 Researchers in New Zealand have warned that long hours sitting in
http://www.guardian.co.uk/online/news/0,12597,884805,00.html

Extractions: Go to: Guardian Unlimited home UK news World news Archive search Arts Books Business EducationGuardian.co.uk Film Football Jobs MediaGuardian.co.uk Money The Observer Online Politics Shopping SocietyGuardian.co.uk Sport Talk Travel Audio Email services Special reports The Guardian The weblog The informer The northerner The wrap Advertising guide Crossword Dating Headline service Syndication services Events / offers Help / contacts Information Newsroom Style guide Travel offers TV listings Weather Web guides Guardian Weekly Money Observer Online home Ask Jack Web watch Gadgets ... Working IT out Researchers in New Zealand have warned that long hours sitting in front of a computer screen could cause deep vein thrombosis (DVT), a condition that has been linked with long-haul flights. Researchers at the New Zealand Medical Research Institute have reported what could be the first known case of "e-thrombosis" in a 32-year-old man who spent between 12 and 18 hours a day working at his computer. He came close to death after developing a massive blood clot that formed in his legs and travelled to his lungs.
Clinical Study: 98-CC-0067, Treatment Of Acute Deep Vein Thrombosis Of The Lower
Summary, detailed information, and eligibility requirements for this National Institutes of Health clinical trial to evaluate the efficiency, safety, and doses of a new spray treatment.
http://clinicalstudies.info.nih.gov/detail/A_1998-CC-0067.html

Extractions: Protocol Number: 98-CC-0067 Treatment of Acute Deep Vein Thrombosis of the Lower Extremity with Intraclot, Pulse-Sprayed Recombinant Tissue Plasminogen Activator, Plus Heparin and Warfarin: A Pilot Study 98-CC-0067 Acute deep venous thrombosis (ADVT) of the lower extremity is a common disorder. Traditional treatment with anticoagulation therapy is effective in reducing the associated risk of pulmonary embolism, but is ineffective in restoring patency of the venous system of the lower extremity. While systemic thrombolytic therapy has been shown to be more effective than anticoagulation, catheter directed local thrombolytic therapy is the most effective treatment in restoring venous patency. Current treatment regimens are based on use of urokinase, infused continuously through catheters imbedded into the thrombus. These treatment regimens require doses on the order of 10,000,000 units of urokinase, resulting in significant bleeding complications and prohibitive costs. Experience at NIH with pulse-spray treatment of axillary subclavian venous thrombosis with rtPA indicates that this is a highly effective and safe alternative thrombolytic regimen. The proposed protocol is designed to evaluate the efficiency, safety, and doses of rtPA associated with pulse spray directed rtPA treatment of the more extensive venous thrombosis encountered in the lower extremity.
CNN.com - Health - Deep Vein Thrombosis Linked To Most Travel - March 13, 2001
International medical experts and officials from 16 major airlines across theglobe on Tuesday heard a leading expert on deep vein thrombosis link the
http://www.cnn.com/2001/HEALTH/conditions/03/13/deep.vein.thrombosis.02/

Extractions: Languages Spanish Portuguese German Italian Danish Japanese Korean Arabic Time, Inc. Time.com People Fortune EW From staff and wire reports GENEVA, Switzerland International medical experts and officials from 16 major airlines across the globe on Tuesday heard a leading expert on deep vein thrombosis link the condition to most types of travel. Organized by the World Health Organization's cardiovascular disease unit, the closed-door meetings in Geneva, Switzerland, began Monday and concluded Tuesday. "Travel-related thrombosis is a better name," Dr. John Scurr, a British surgeon who has studied the syndrome, told Reuters. "Studies have shown it is a common travel problem." Scurr is a surgeon at Middlesex and University College Hospital in London, England. PREVENTION Snacking, moving can decrease risk of flight-related blood clots Also speaking Tuesday was Dr. Derek Yach of the WHO, who agreed with Scurr that deep vein thrombosis is probably a bigger issue than it currently appears to be. Physicians say the condition is still rare, however. Gregory Hartl, a spokesman for the United Nations health agency, called the two-day meeting significant. "We've come to this with an open mind. We need to review the research done and see what gaps need filling and what, how and when it needs to be done on an international scale," he told The Associated Press.
PREVENT (Prevention Of Recurrent Venous Thromboembolism) Trial
Aims to answer the question What is the best way to prevent the recurrence of blood clots in the legs and lungs? Features background information about thrombosis and its treatment plus information about the trial and patient eligibility.
http://www.brighamandwomens.org/patient/optionalInterpage.asp?rso_abbrev=bwh&
Cerebral Thrombosis
Describes in detail how TCM practitioners in China solve this with traditional Chinese strategies and herbs.Category Health Conditions and Diseases thrombosis Cerebral thrombosis is also recognized as atherosclerotic and thrombotic cerebralinfarction and is caused by the pathological changes of cerebral arterial
http://www.tcmtreatment.com/images/diseases/cerebral-thrombosis.htm

Extractions: Cerebral thrombosis is also recognized as atherosclerotic and thrombotic cerebral infarction and is caused by the pathological changes of cerebral arterial wall together with elevation of blood coagulability, leading to vascular narrowness, obstruction and ischemic changes of the corresponding cerebral tissue, which may be followed by necrosis. This disease, in TCM, is included in the category of "zhong feng" (apoplexy). Main Points of Diagnosis 1. The disease is more common in middle-aged and old people. There may be transient numbness of limbs, fatigue and aphasia before the onset of the disease. 2. The attack often occurs in sleep, when te blood pressure is lower and blood flow is slower. A few cases may be seen after strenuous exercise. 3. Neural manifestations include central monoplegia and hemiplegia. They may be accompanied with aphasia, but are often with hemihypoesthesia and hemianopia. There may also be disphagia and disturbance of consciousness. Unilateral optic atrophy and Horner's syndrome may be present. 4. Cerebrospinal fluid examination shows no change in pressure and cell content. This can be used to distinguish cerebral thrombosis form cerebral hemorrhage. CT scanning is helpful in the determination of location and extent of cerebral necrosis.
Deep Leg Vein Thrombosis
Treatment of deep leg vein thrombosis there is a comment for consumers on this articleAS Gallus, Department of Haematology, Flinders Medical Centre, Adelaide.
http://www.australianprescriber.com/magazines/vol21no3/vein_thrombosis.htm

Extractions: The management of established thrombosis has been transformed by low molecular weight heparins. Their pharmacokinetics and dynamics allow them to be given subcutaneously in a dose determined by body weight alone. While this permits treatment of selected patients at home, great care is needed. The correct diagnosis remains essential because the risks of early recurrence and bleeding are little different from those observed with standard heparin. Symptomatic calf vein thrombosis should be treated. Sixty years ago, before heparin came into general use, symptoms of deep leg vein thrombosis progressed from calf to thigh or to the opposite leg in 60% of untreated patients. Embolism occurred in 40% of those with thrombosis and half the patients with pulmonary embolism died. Today, we expect symptomatic extension or embolism in less than 5% of people treated for extensive deep leg vein thrombosis with standard heparin or a low molecular weight heparin followed by warfarin. Deaths from pulmonary embolism should be below 2%.
Organon - International
thrombosis, Blood clots a major cause of death and disability, Arterial thrombosiscan result in myocardial infarction, stroke and peripheral vascular disease.
http://www.organon.com/products/thrombosis/index.asp

Extractions: Thrombosis, the unwanted formation of a blood clot in an unbreached blood vessel, is one of the major causes of death and disability in the western world. Deep vein thrombosis , a common yet preventable complication of many medical disorders and major surgery, can lead to the fatal condition of pulmonary embolism. Arterial thrombosis can result in myocardial infarction, stroke and peripheral vascular disease. Organon first marketed heparin, a natural product that prevents blood clotting, in 1948. More recent research efforts in collaboration with Sanofi-Synthelabo have resulted in the discovery and development of Arixtra®, a novel antithrombotic agent anticipated to significantly improve the therapeutic management of patients at risk of thrombosis. Organon remains committed to the further research and development of compounds for the prevention and treatment of thrombosis.
Organon - International
Homepage News Events Congress Calendar thrombosis. Contraception. HRT Osteoporosis. Fertility. Mental health. thrombosis. Anesthesia. Others.
http://www.organon.com/news/dates/thrombosis/index.asp

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

61-80 of 126 Back | 1 | 2 | 3 | 4 | 5 | 6 | 7 | Next 20